首页 > 最新文献

Journal of pancreatology最新文献

英文 中文
Artery encasement on preoperative CT scan does not preclude radical surgery: a case report utilizing sub-adventitial divestment for artery-involving pancreatic cancer. 术前CT扫描显示的动脉包膜不排除根治性手术:一例使用亚外动脉剥离治疗动脉累及胰腺癌的病例报告。
Pub Date : 2022-10-11 DOI: 10.1097/jp9.0000000000000100
B. Cai, Zipeng Lu, Y. Miao
{"title":"Artery encasement on preoperative CT scan does not preclude radical surgery: a case report utilizing sub-adventitial divestment for artery-involving pancreatic cancer.","authors":"B. Cai, Zipeng Lu, Y. Miao","doi":"10.1097/jp9.0000000000000100","DOIUrl":"https://doi.org/10.1097/jp9.0000000000000100","url":null,"abstract":"","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44353140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GSDME with a moonlighting function in pancreatic ductal adenocarcinoma: a narrative review GSDME在胰腺导管腺癌中具有兼职功能:一篇叙述性综述
Pub Date : 2022-10-11 DOI: 10.1097/JP9.0000000000000104
Bo-Nian Huang
Pancreatic ductal adenocarcinoma (PDAC) originates in the exocrine pancreas and accounts for 95% of pancreatic cancers, with 5-year survival rates of approximately 10%. Multiple factors are involved in PDAC pathogenesis, including internal genetic alterations and external inflammation-related stimuli. Overflow of exocrine pancreatic enzymes caused by PDAC obstruction inevitably results in autolysis of surrounding normal cells and extracellular matrix, generating tissue damage-related inflammation; however, this process does not cause autolysis of PDAC cells. How tumor cells acquire resistance to pancreatic enzymatic digestion has been ignored for a long time. In this review, we discuss how PDAC cells mobilize gasdermin E, a pore-forming protein, to achieve resistance to autolysis by pancreatic digestive enzymes.
胰腺导管腺癌(PDAC)起源于外分泌胰腺,占胰腺癌的95%,5年生存率约为10%。PDAC的发病机制涉及多种因素,包括内部基因改变和外部炎症相关刺激。PDAC梗阻引起的胰腺外分泌酶溢出不可避免地导致周围正常细胞和细胞外基质自溶,产生组织损伤相关炎症;然而,该过程不会引起PDAC细胞的自溶。长期以来,肿瘤细胞如何获得对胰腺酶消化的抗性一直被忽视。在这篇综述中,我们讨论了PDAC细胞如何动员气孔形成蛋白gasdermin E,以实现对胰腺消化酶自溶的抵抗。
{"title":"GSDME with a moonlighting function in pancreatic ductal adenocarcinoma: a narrative review","authors":"Bo-Nian Huang","doi":"10.1097/JP9.0000000000000104","DOIUrl":"https://doi.org/10.1097/JP9.0000000000000104","url":null,"abstract":"Pancreatic ductal adenocarcinoma (PDAC) originates in the exocrine pancreas and accounts for 95% of pancreatic cancers, with 5-year survival rates of approximately 10%. Multiple factors are involved in PDAC pathogenesis, including internal genetic alterations and external inflammation-related stimuli. Overflow of exocrine pancreatic enzymes caused by PDAC obstruction inevitably results in autolysis of surrounding normal cells and extracellular matrix, generating tissue damage-related inflammation; however, this process does not cause autolysis of PDAC cells. How tumor cells acquire resistance to pancreatic enzymatic digestion has been ignored for a long time. In this review, we discuss how PDAC cells mobilize gasdermin E, a pore-forming protein, to achieve resistance to autolysis by pancreatic digestive enzymes.","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":"5 1","pages":"198 - 201"},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45443853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing, approach, and treatment strategies for infected pancreatic necrosis: a narrative review 感染性胰腺坏死的时机、方法和治疗策略:叙述性综述
Pub Date : 2022-10-11 DOI: 10.1097/JP9.0000000000000105
F. Cao, W. Mei, Fei Li
ancreatic necrosis occurs in approximately 15% to 20% of patients with acute pancreatitis (AP); 1/3 of patients are diagnosed with infected pancreatic necrosis (IPN), which has a mortality rate of 30%. It is the chief reason for the second “death peak” of AP patients in the later stage of the disease. [1] As one of the most vital treatment methods for IPN, pancreatic necrosectomy has developed rapidly in the past 30 years, including improvements and breakthroughs in surgical timing, approach, and strategies, and a significant reduction in postoperative mortality from the initial 30% to 40%. In particular, with the innovation of laparoscopic and endoscopic tech- niques, pancreatic surgeons have more choices in the face of IPN. Currently, how to optimize treatment and maximize the benefits for IPN patients has become a topic of great concern and controversy in the treatment of IPN.
胰腺坏死发生在约15%至20%的急性胰腺炎(AP)患者中;1/3的患者被诊断为感染性胰腺坏死(IPN),其死亡率为30%。这是AP患者在疾病后期出现第二个“死亡高峰”的主要原因。[1] 作为IPN最重要的治疗方法之一,胰腺坏死切除术在过去30年中发展迅速,包括手术时机、方法和策略的改进和突破,术后死亡率从最初的30%显著降低到40%。特别是,随着腹腔镜和内窥镜技术的创新,胰腺外科医生在IPN面前有了更多的选择。目前,如何为IPN患者优化治疗,实现效益最大化,已成为IPN治疗中备受关注和争议的话题。
{"title":"Timing, approach, and treatment strategies for infected pancreatic necrosis: a narrative review","authors":"F. Cao, W. Mei, Fei Li","doi":"10.1097/JP9.0000000000000105","DOIUrl":"https://doi.org/10.1097/JP9.0000000000000105","url":null,"abstract":"ancreatic necrosis occurs in approximately 15% to 20% of patients with acute pancreatitis (AP); 1/3 of patients are diagnosed with infected pancreatic necrosis (IPN), which has a mortality rate of 30%. It is the chief reason for the second “death peak” of AP patients in the later stage of the disease. [1] As one of the most vital treatment methods for IPN, pancreatic necrosectomy has developed rapidly in the past 30 years, including improvements and breakthroughs in surgical timing, approach, and strategies, and a significant reduction in postoperative mortality from the initial 30% to 40%. In particular, with the innovation of laparoscopic and endoscopic tech- niques, pancreatic surgeons have more choices in the face of IPN. Currently, how to optimize treatment and maximize the benefits for IPN patients has become a topic of great concern and controversy in the treatment of IPN.","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":"5 1","pages":"159 - 163"},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44677971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exosome-mediated cell–cell communication within pancreatic cancer tumor microenvironment: a narrative review 胰腺癌症肿瘤微环境中外源介导的细胞-细胞通讯:叙述性综述
Pub Date : 2022-10-11 DOI: 10.1097/JP9.0000000000000108
Cheng Qin, Bangbo Zhao, Yuanyang Wang, Tianhao Li, Zeru Li, Tianyu Li, Yutong Zhao, Weibin Wang
The significance of exosomes has emerged in a variety of physiological processes and diseases. Pancreatic cancer remains one of the most lethal diseases at present. Recently, increasing evidence has suggested that exosomes are vital for mediating the elaborate interaction of highly heterogeneous cell clusters within the pancreatic tumor microenvironment, contributing to activating pancreatic stellate cells and cancer-associated fibroblasts, compromising immune cells, and enhancing angiogenesis. Besides their natural and intrinsic roles, exosomes may provide a novel potential way for pancreatic cancer management and therapy as well. Thus, exosomes not only mediate cellular communication during pancreatic cancer progression but also serve as a promising player in precise pancreatic cancer management and treatment. To comprehensively summarize the role of exosomes in pancreatic cancer, we searched the PubMed database and reviewed all relevant original studies.
外泌体的意义已经在各种生理过程和疾病中显现出来。胰腺癌仍然是目前最致命的疾病之一。最近,越来越多的证据表明,外泌体对于介导胰腺肿瘤微环境中高度异质细胞团的复杂相互作用至关重要,有助于激活胰腺星状细胞和癌症相关成纤维细胞,损害免疫细胞,并促进血管生成。外泌体除了具有天然和内在的作用外,还可能为胰腺癌的管理和治疗提供一种新的潜在途径。因此,外泌体不仅在胰腺癌进展过程中介导细胞通讯,而且在胰腺癌的精确管理和治疗中发挥着重要作用。为了全面总结外泌体在胰腺癌中的作用,我们检索了PubMed数据库并回顾了所有相关的原始研究。
{"title":"Exosome-mediated cell–cell communication within pancreatic cancer tumor microenvironment: a narrative review","authors":"Cheng Qin, Bangbo Zhao, Yuanyang Wang, Tianhao Li, Zeru Li, Tianyu Li, Yutong Zhao, Weibin Wang","doi":"10.1097/JP9.0000000000000108","DOIUrl":"https://doi.org/10.1097/JP9.0000000000000108","url":null,"abstract":"The significance of exosomes has emerged in a variety of physiological processes and diseases. Pancreatic cancer remains one of the most lethal diseases at present. Recently, increasing evidence has suggested that exosomes are vital for mediating the elaborate interaction of highly heterogeneous cell clusters within the pancreatic tumor microenvironment, contributing to activating pancreatic stellate cells and cancer-associated fibroblasts, compromising immune cells, and enhancing angiogenesis. Besides their natural and intrinsic roles, exosomes may provide a novel potential way for pancreatic cancer management and therapy as well. Thus, exosomes not only mediate cellular communication during pancreatic cancer progression but also serve as a promising player in precise pancreatic cancer management and treatment. To comprehensively summarize the role of exosomes in pancreatic cancer, we searched the PubMed database and reviewed all relevant original studies.","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":"6 1","pages":"1 - 7"},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45022710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical application of 3D reconstruction in pancreatic surgery: a narrative review 三维重建在胰腺外科的临床应用综述
Pub Date : 2022-10-11 DOI: 10.1097/JP9.0000000000000107
Yiming Zhang, Yuanyuan Yang, Shu-jie Chen, Jianbing Ji, Huiting Ge, Heguang Huang
Progress in medicine requires not only innovation and development in the medical field but also the integration of the technology of other fields into the medical field. As an important technological advancement, three-dimensional (3D) reconstruction transforms traditional two-dimensional images into 3D images that are more consistent with the physiological habits of human eyes. It has been applied to the bones, heart, liver, and maxillofacial area, promoting the progress of medical technology and surgeons. This article introduces the progress of 3D reconstruction technology in the clinical application of pancreatic surgery, from the preoperative, intraoperative, and postoperative perspectives, as well as the education of young surgeons. It also puts forward new ideas for the further development of pancreatic surgery.
医学的进步不仅需要医学领域的创新和发展,还需要将其他领域的技术融入医学领域。作为一项重要的技术进步,三维重建将传统的二维图像转化为更符合人眼生理习惯的三维图像。它已被应用于骨骼、心脏、肝脏和颌面部,促进了医学技术和外科医生的进步。本文从术前、术中、术后三个方面介绍了三维重建技术在胰腺外科临床应用中的进展,以及对年轻外科医生的教育。也为胰腺外科的进一步发展提出了新的思路。
{"title":"Clinical application of 3D reconstruction in pancreatic surgery: a narrative review","authors":"Yiming Zhang, Yuanyuan Yang, Shu-jie Chen, Jianbing Ji, Huiting Ge, Heguang Huang","doi":"10.1097/JP9.0000000000000107","DOIUrl":"https://doi.org/10.1097/JP9.0000000000000107","url":null,"abstract":"Progress in medicine requires not only innovation and development in the medical field but also the integration of the technology of other fields into the medical field. As an important technological advancement, three-dimensional (3D) reconstruction transforms traditional two-dimensional images into 3D images that are more consistent with the physiological habits of human eyes. It has been applied to the bones, heart, liver, and maxillofacial area, promoting the progress of medical technology and surgeons. This article introduces the progress of 3D reconstruction technology in the clinical application of pancreatic surgery, from the preoperative, intraoperative, and postoperative perspectives, as well as the education of young surgeons. It also puts forward new ideas for the further development of pancreatic surgery.","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":"6 1","pages":"18 - 22"},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48590164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of antagonist peptides and chelators on the diagnostic performance of PET/CT using gallium-68–labeled somatostatin receptor antagonists 拮抗肽和螯合剂对使用镓-68标记生长抑素受体拮抗剂的PET/CT诊断性能的影响
Pub Date : 2022-10-11 DOI: 10.1097/JP9.0000000000000101
Haiqun Xing, Wenjia Zhu, Yue-juan Cheng, Qiao Yang, R. Jia, Hongguang Zhao, C. Bai, Li Huo, Wenming Wu
Objective: Different SSTR2 antagonists have been developed. This study aims to evaluate the impact of different peptides and chelators on the diagnostic performance of SSTR2 antagonists in well-differentiated NETs. Methods: In this prospective study, participants were equally randomized into 2 arms: arm A, participants would undergo a whole-body 68Ga-NODAGA-LM3 PET/CT scan on the first day and 68Ga-DOTA-LM3 PET/CT scan on the second day; arm B, participants would undergo a whole-body 68Ga-NODAGA-LM3 PET/CT scan on the first day and 68Ga-NODAGA-JR11 PET/CT scan on the second day. Biodistribution in normal organs, lesion detection ability, and tumor uptakes were compared within each arm. Results: A total of 40 participants (age, 49.5 ± 13.4, 21 men), 20 in each arm, were recruited in the study. In arm A, 68Ga-DOTA-LM3 showed lower background. However, the lesion detection ability (overall lesion detected, 445 vs 548; P = .005) and the lesion uptake (overall lesions SUVmax, 19.8 ± 17.2 vs 35.3 ± 28.8; P < .001) was significantly lower than those of 68Ga-NODAGA-LM3. In arm B, both 68Ga-NODAGA-LM3 and 68Ga-NODAGA-JR11 showed similar biodistribution and lesion uptake (SUVmax, 28.5 ± 23.8 vs 25.0 ± 20.0; P < .001) despite minor differences. The lesion detection ability was the same between these 2 tracers (overall lesion detected, 503 vs 503). Conclusions: The diagnostic performance of SSTR2 antagonists was sensitive to chelators. Both 68Ga-NODAGA-LM3 and 68Ga-NODAGA-JR11 outperformed 68Ga-DOTA-LM3 with higher lesion uptake and detection ability, of which 68Ga-NODAGA-LM3 had marginally but significantly higher lesion uptake.
目的:已开发出不同的SSTR2拮抗剂。本研究旨在评估不同肽和螯合剂对SSTR2拮抗剂在高分化NETs中诊断性能的影响。方法:在这项前瞻性研究中,参与者被平均随机分为两组:A组,参与者将在第一天接受全身68Ga-NODAGA-LM3 PET/CT扫描,第二天接受68Ga-DOTA-LM3 PET/CT扫查;臂B,参与者将在第一天接受全身68Ga-NODAGA-LM3 PET/CT扫描,并在第二天接受68Ga-NOD AGA-JR11 PET/CT扫查。在每只手臂内比较正常器官中的生物分布、病变检测能力和肿瘤摄取量。结果:共有40名参与者(年龄49.5岁) ± 13.4,21名男性),每只手臂20名。在臂A中,68Ga-DOTA-LM3显示出较低的背景。然而,病变检测能力(检测到的总病变,445 vs 548;P=0.005)和病变摄取(总病变SUVmax,19.8 ± 17.2对35.3 ± 28.8;P<0.001)显著低于68Ga-NODAGA-LM3。在B组中,68Ga-NODAGA-LM3和68Ga-NOD AGA-JR11均显示出相似的生物分布和病变摄取(SUVmax,28.5 ± 23.8对25.0 ± 20.0;P<0.001)。这两种示踪剂的病变检测能力相同(检测到的总病变为503 vs 503)。结论:SSTR2拮抗剂的诊断性能对螯合剂敏感。68Ga-NODAGA-LM3和68Ga-NOD AGA-JR11均优于68Ga-DOTA-LM3,具有更高的病变摄取和检测能力,其中68Ga-NODAGA-LM三具有略微但显著更高的损伤摄取。
{"title":"Impact of antagonist peptides and chelators on the diagnostic performance of PET/CT using gallium-68–labeled somatostatin receptor antagonists","authors":"Haiqun Xing, Wenjia Zhu, Yue-juan Cheng, Qiao Yang, R. Jia, Hongguang Zhao, C. Bai, Li Huo, Wenming Wu","doi":"10.1097/JP9.0000000000000101","DOIUrl":"https://doi.org/10.1097/JP9.0000000000000101","url":null,"abstract":"Objective: Different SSTR2 antagonists have been developed. This study aims to evaluate the impact of different peptides and chelators on the diagnostic performance of SSTR2 antagonists in well-differentiated NETs. Methods: In this prospective study, participants were equally randomized into 2 arms: arm A, participants would undergo a whole-body 68Ga-NODAGA-LM3 PET/CT scan on the first day and 68Ga-DOTA-LM3 PET/CT scan on the second day; arm B, participants would undergo a whole-body 68Ga-NODAGA-LM3 PET/CT scan on the first day and 68Ga-NODAGA-JR11 PET/CT scan on the second day. Biodistribution in normal organs, lesion detection ability, and tumor uptakes were compared within each arm. Results: A total of 40 participants (age, 49.5 ± 13.4, 21 men), 20 in each arm, were recruited in the study. In arm A, 68Ga-DOTA-LM3 showed lower background. However, the lesion detection ability (overall lesion detected, 445 vs 548; P = .005) and the lesion uptake (overall lesions SUVmax, 19.8 ± 17.2 vs 35.3 ± 28.8; P < .001) was significantly lower than those of 68Ga-NODAGA-LM3. In arm B, both 68Ga-NODAGA-LM3 and 68Ga-NODAGA-JR11 showed similar biodistribution and lesion uptake (SUVmax, 28.5 ± 23.8 vs 25.0 ± 20.0; P < .001) despite minor differences. The lesion detection ability was the same between these 2 tracers (overall lesion detected, 503 vs 503). Conclusions: The diagnostic performance of SSTR2 antagonists was sensitive to chelators. Both 68Ga-NODAGA-LM3 and 68Ga-NODAGA-JR11 outperformed 68Ga-DOTA-LM3 with higher lesion uptake and detection ability, of which 68Ga-NODAGA-LM3 had marginally but significantly higher lesion uptake.","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":"6 1","pages":"28 - 33"},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45634219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute necrotizing pancreatitis: challenges and interventions—a narrative review 急性坏死性胰腺炎:挑战与干预——叙述性综述
Pub Date : 2022-10-11 DOI: 10.1097/JP9.0000000000000103
Yongde Luo, Le Li, R. Kong, Y. Sui, Bei Sun
Acute pancreatitis (AP) is a complicated disease with rising incidence over the years. Twenty percent of AP will develop into acute necrotizing pancreatitis (ANP). Interventions for ANP have evolved from traditional open surgery to minimally invasive step-up approaches. Infected pancreatic necrosis (IPN) is the most serious event of ANP and associated with extremely poor prognosis. The contrast-enhanced computed tomography(CECT)-based classification of IPN describes various types of IPN and will help to carry out surgical interventions for each subtype. Nevertheless, many challenges are still remaining during the treatment of ANP. Including the balance between endoscopic and surgical approaches, and the selection of optimal timing of surgical intervention for infected necrosis. In nowadays treatment scenario of ANP, the necessity for open surgery remains to be debated. Despite of the development of advanced interventional techniques, postoperative residual infection (PRI) remains thorny, and effective prevention and treatment of PRI is of significance.
急性胰腺炎(AP)是一种复杂的疾病,近年来发病率不断上升。20%的AP会发展为急性坏死性胰腺炎(ANP)。ANP的干预措施已经从传统的开放手术发展到微创强化方法。感染性胰腺坏死(IPN)是ANP最严重的事件,预后极差。基于对比增强计算机断层扫描(CECT)的IPN分类描述了各种类型的IPN,并将有助于对每种亚型进行手术干预。然而,在ANP的治疗过程中仍然存在许多挑战。包括内窥镜和手术入路之间的平衡,以及感染性坏死手术干预的最佳时机选择。在目前ANP的治疗方案中,开放性手术的必要性仍然存在争议。尽管介入技术越来越先进,但术后残留感染(PRI)仍然是一个棘手的问题,有效预防和治疗PRI具有重要意义。
{"title":"Acute necrotizing pancreatitis: challenges and interventions—a narrative review","authors":"Yongde Luo, Le Li, R. Kong, Y. Sui, Bei Sun","doi":"10.1097/JP9.0000000000000103","DOIUrl":"https://doi.org/10.1097/JP9.0000000000000103","url":null,"abstract":"Acute pancreatitis (AP) is a complicated disease with rising incidence over the years. Twenty percent of AP will develop into acute necrotizing pancreatitis (ANP). Interventions for ANP have evolved from traditional open surgery to minimally invasive step-up approaches. Infected pancreatic necrosis (IPN) is the most serious event of ANP and associated with extremely poor prognosis. The contrast-enhanced computed tomography(CECT)-based classification of IPN describes various types of IPN and will help to carry out surgical interventions for each subtype. Nevertheless, many challenges are still remaining during the treatment of ANP. Including the balance between endoscopic and surgical approaches, and the selection of optimal timing of surgical intervention for infected necrosis. In nowadays treatment scenario of ANP, the necessity for open surgery remains to be debated. Despite of the development of advanced interventional techniques, postoperative residual infection (PRI) remains thorny, and effective prevention and treatment of PRI is of significance.","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":"5 1","pages":"164 - 173"},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42794694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digestive tract reconstruction in pancreaticoduodenectomy in University Hospitals of China: a national questionnaire survey 中国大学附属医院胰十二指肠切除术后消化道重建:一项全国性问卷调查
Pub Date : 2022-10-11 DOI: 10.1097/JP9.0000000000000106
Jishu Wei, Q. Xu, Yuhua Zhang, Jiabin Jin, Xiaodong Tian, Qiaofei Liu, Zipeng Lu, Zheng-kun Wang, S. Gou, Song Gao, Xianlin Han, Y. Rong, Niandong Ji, Ye Lin, Guolin Li, Shi-You Chen, F. Cao, Hua Chen, Wenming Wu, Yupei Zhao
Background: Pancreaticoduodenectomy (PD) has been widely applied in general hospitals in China; however, there is still a lack of unified standards for each surgical technique and procedure. This survey is intended to investigate the current status of digestive tract reconstruction after PD in university hospitals in China. Method: A cross-sectional survey was conducted among the members of the Young Elite Pancreatic Surgery Club of China by using the Questionnaire for Digestive Tract Reconstruction after Pancreaticoduodenectomy. The questionnaire was disseminated and collected by point-to-point communication via WeChat public platforms. Results: A total of 73 valid questionnaires were returned from 65 university hospitals in 28 provincial divisions of mainland China. The respondents who performed PD surgery with an annual volume of over 100 cases accounted for 63%. Generally, laparoscopic PD was performed less often than open PD. Child and Whipple reconstructions accounted for 70% and 26%, respectively. The sequence of pancreatoenteric, biliary-enteric, and gastrointestinal reconstruction accounted for 84% of cases. In pancreatoenteric anastomosis, double-layer anastomosis is the most commonly employed type, accounting for approximately 67%, while single-layer anastomosis accounts for 30%. Of the double-layer anastomoses, duct-to-mucosa/dunking (94%/4%) pancreatojejunostomy was performed with duct-mucosa using the Blumgart method (39%) and Cattel-Warren (29%), with continuous/interrupted sutures in the inner layer (69%/31%) and continuous/interrupted sutures in the outer layer (53%/23%). In single-layer anastomosis, continuous/interrupted sutures accounted for 41%/45%. In hepatojejunostomy, single-layer/double-layer suture accounted for 79%/4%, and continuous/interrupted suture accounted for 75%/9%. Forty-six percent of the responding units had not applied double-layer biliary-intestinal anastomosis in the last 3 years, 75% of the responding surgeons chose the anastomosis method according to bile duct diameter, with absorbable/non-absorbable suture accounting for 86%/12%. PD/pylorus-preserving PD accounted for 79%/11% of gastrojejunostomy (GJ) cases, the distance between GJ and hepaticojejunostomy < 30, 30–50, and > 50 cm were 11%, 75%, and 14%, respectively. Antecolic/retrocolic GJ accounted for 71%/23% of cases. Twenty-two percent of GJ cases employed Braun anastomosis, while 55% and 19% of GJ cases used linear cutting staplers/tube-type staplers, respectively; 60%/14% were reinforced/not reinforced via manual suturing after stapler anastomosis. Manual anastomosis in GJ surgery employed absorbable/non-absorbable sutures (91%/9%). Significant differences in reconstruction techniques were detected between different volumes of PD procedures (<100/year and >100/year), regions with different economic development levels, and between north and south China. Conclusion: Digestive tract reconstruction following PD exists heterogeneity in Chinese univers
背景:胰十二指肠切除术(PD)在国内综合医院已得到广泛应用;然而,对于每一种手术技术和程序,目前仍缺乏统一的标准。本调查旨在了解国内大学医院PD术后消化道重建的现状。方法:采用《胰十二指肠切除术后消化道重建问卷》对中国青年胰腺外科精英俱乐部会员进行横断面调查。问卷通过微信公共平台进行点对点传播收集。结果:共回收有效问卷73份,来自中国大陆28个省区的65所大学医院。每年进行PD手术量超过100例的受访者占63%。一般来说,腹腔镜PD比开放式PD更少。儿童和惠普尔重建分别占70%和26%。胰肠、胆道肠和胃肠重建顺序占84%。在胰肠吻合术中,最常用的是双层吻合术,约占67%,而单层吻合术占30%。双层吻合术中,胰空肠吻合术采用Blumgart法(39%)和Cattel-Warren法(29%),导管-粘膜/灌肠(94%/4%)吻合,内层连续/间断缝合(69%/31%),外层连续/间断缝合(53%/23%)。单层吻合中,连续缝合/间断缝合占41%/45%。在肝空肠吻合中,单层/双层缝合占79%/4%,连续/间断缝合占75%/9%。46%的应答单位近3年未应用双层胆肠吻合术,75%的应答医师根据胆管直径选择吻合方式,可吸收/不可吸收缝合占86%/12%。保幽门PD/保幽门PD分别占胃空肠造口术(GJ)病例的79%/11%,GJ距肝空肠造口距离< 30、30 - 50、50 ~ 50 cm分别占11%、75%、14%。绞痛前/绞痛后GJ占71%/23%。采用布朗吻合术的占22%,采用线切割吻合器的占55%,采用管状吻合器的占19%;吻合器吻合后手工缝合加固/不加固的占60%/14%。GJ手术中手工吻合采用可吸收缝线/不可吸收缝线(91%/9%)。不同PD手术量(100次/年)、不同经济发展水平地区以及中国南北之间的重建技术存在显著差异。结论:我国大学附属医院PD术后消化道重建存在异质性。需要相应的前瞻性临床研究来确定符合中国临床实际的胰腺手术共识。
{"title":"Digestive tract reconstruction in pancreaticoduodenectomy in University Hospitals of China: a national questionnaire survey","authors":"Jishu Wei, Q. Xu, Yuhua Zhang, Jiabin Jin, Xiaodong Tian, Qiaofei Liu, Zipeng Lu, Zheng-kun Wang, S. Gou, Song Gao, Xianlin Han, Y. Rong, Niandong Ji, Ye Lin, Guolin Li, Shi-You Chen, F. Cao, Hua Chen, Wenming Wu, Yupei Zhao","doi":"10.1097/JP9.0000000000000106","DOIUrl":"https://doi.org/10.1097/JP9.0000000000000106","url":null,"abstract":"Background: Pancreaticoduodenectomy (PD) has been widely applied in general hospitals in China; however, there is still a lack of unified standards for each surgical technique and procedure. This survey is intended to investigate the current status of digestive tract reconstruction after PD in university hospitals in China. Method: A cross-sectional survey was conducted among the members of the Young Elite Pancreatic Surgery Club of China by using the Questionnaire for Digestive Tract Reconstruction after Pancreaticoduodenectomy. The questionnaire was disseminated and collected by point-to-point communication via WeChat public platforms. Results: A total of 73 valid questionnaires were returned from 65 university hospitals in 28 provincial divisions of mainland China. The respondents who performed PD surgery with an annual volume of over 100 cases accounted for 63%. Generally, laparoscopic PD was performed less often than open PD. Child and Whipple reconstructions accounted for 70% and 26%, respectively. The sequence of pancreatoenteric, biliary-enteric, and gastrointestinal reconstruction accounted for 84% of cases. In pancreatoenteric anastomosis, double-layer anastomosis is the most commonly employed type, accounting for approximately 67%, while single-layer anastomosis accounts for 30%. Of the double-layer anastomoses, duct-to-mucosa/dunking (94%/4%) pancreatojejunostomy was performed with duct-mucosa using the Blumgart method (39%) and Cattel-Warren (29%), with continuous/interrupted sutures in the inner layer (69%/31%) and continuous/interrupted sutures in the outer layer (53%/23%). In single-layer anastomosis, continuous/interrupted sutures accounted for 41%/45%. In hepatojejunostomy, single-layer/double-layer suture accounted for 79%/4%, and continuous/interrupted suture accounted for 75%/9%. Forty-six percent of the responding units had not applied double-layer biliary-intestinal anastomosis in the last 3 years, 75% of the responding surgeons chose the anastomosis method according to bile duct diameter, with absorbable/non-absorbable suture accounting for 86%/12%. PD/pylorus-preserving PD accounted for 79%/11% of gastrojejunostomy (GJ) cases, the distance between GJ and hepaticojejunostomy < 30, 30–50, and > 50 cm were 11%, 75%, and 14%, respectively. Antecolic/retrocolic GJ accounted for 71%/23% of cases. Twenty-two percent of GJ cases employed Braun anastomosis, while 55% and 19% of GJ cases used linear cutting staplers/tube-type staplers, respectively; 60%/14% were reinforced/not reinforced via manual suturing after stapler anastomosis. Manual anastomosis in GJ surgery employed absorbable/non-absorbable sutures (91%/9%). Significant differences in reconstruction techniques were detected between different volumes of PD procedures (<100/year and >100/year), regions with different economic development levels, and between north and south China. Conclusion: Digestive tract reconstruction following PD exists heterogeneity in Chinese univers","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":"5 1","pages":"151 - 158"},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47720097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visceral debranching followed by chemotherapy and resection for locally advanced pancreatic cancer with arterial invasion: a case report 局部晚期侵犯动脉的癌症内脏清支后化疗切除1例报告
Pub Date : 2022-10-11 DOI: 10.1097/jp9.0000000000000098
U. Ronellenfitsch, A. Rebelo, J. Kleeff
{"title":"Visceral debranching followed by chemotherapy and resection for locally advanced pancreatic cancer with arterial invasion: a case report","authors":"U. Ronellenfitsch, A. Rebelo, J. Kleeff","doi":"10.1097/jp9.0000000000000098","DOIUrl":"https://doi.org/10.1097/jp9.0000000000000098","url":null,"abstract":"","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49509116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The learning curve for robot-assisted distal pancreatectomy: a single-center experience of 301 cases. 机器人辅助远端胰腺切除术的学习曲线:单中心 301 例病例的经验。
Pub Date : 2022-09-01 Epub Date: 2022-08-29 DOI: 10.1097/JP9.0000000000000096
Qiang Xu, Tiantong Liu, Xi Zou, Pengyu Li, Ruichen Gao, Menghua Dai, Junchao Guo, Taiping Zhang, Quan Liao, Ziwen Liu, Weibin Wang, Lin Cong, Wenming Wu, Yupei Zhao

Robotic distal pancreatectomy (RDP) has become a routine procedure in many pancreatic centers. This study aimed to describe a single-center experience with RDP since the first case, identify the learning curves of operation time and complication rate, and discuss the safety and feasibility of RDP.

Methods: We collected and retrospectively analyzed the single-center surgical experience of 301 patients undergoing RDP at Peking Union Medical College Hospital (PUMCH) between 2012 and 2022 and described the change in operation proficiency and occurrence of perioperative complications in this observational study. The learning curve was assessed using the cumulative sum method.

Results: We observed a three-phase pattern of RDP learning with operation time, complications, and postoperative pancreatic fistula as indicators and a two-phase pattern for spleening-preserving success. The mean operation time was 3.9 hours. The incidence rate of clinically significant postoperative pancreatic fistula (CRPOPF) was 17.9% and overall Clavien-Dindo complication rate (≥3) was 16.6%. The change of postoperative complicate rate was correlated with percentage of malignant cases.

Conclusion: In the last decade, an evident decrease was seen in operation time, complication rate, and an increase in the spleen-preserving rate of distal pancreatectomy. With proper training, RDP is a safe and feasible procedure.

机器人胰腺远端切除术(RDP)已成为许多胰腺中心的常规手术。本研究旨在描述单中心自第一例机器人胰腺远端切除术以来的经验,确定手术时间和并发症发生率的学习曲线,并讨论机器人胰腺远端切除术的安全性和可行性:我们收集并回顾性分析了2012年至2022年间北京协和医院单中心301例RDP患者的手术经验,并在该观察性研究中描述了手术熟练程度和围术期并发症发生率的变化。采用累积总和法评估学习曲线:我们观察到了以手术时间、并发症和术后胰瘘为指标的三阶段RDP学习模式,以及以保脾成功为指标的两阶段模式。平均手术时间为 3.9 小时。术后有临床意义的胰瘘(CRPOPF)发生率为 17.9%,Clavien-Dindo 并发症总发生率(≥3)为 16.6%。术后并发症发生率的变化与恶性病例的百分比相关:结论:近十年来,胰腺远端切除术的手术时间、并发症发生率明显减少,保留脾脏的发生率增加。通过适当的培训,RDP 是一种安全可行的手术。
{"title":"The learning curve for robot-assisted distal pancreatectomy: a single-center experience of 301 cases.","authors":"Qiang Xu, Tiantong Liu, Xi Zou, Pengyu Li, Ruichen Gao, Menghua Dai, Junchao Guo, Taiping Zhang, Quan Liao, Ziwen Liu, Weibin Wang, Lin Cong, Wenming Wu, Yupei Zhao","doi":"10.1097/JP9.0000000000000096","DOIUrl":"10.1097/JP9.0000000000000096","url":null,"abstract":"<p><p>Robotic distal pancreatectomy (RDP) has become a routine procedure in many pancreatic centers. This study aimed to describe a single-center experience with RDP since the first case, identify the learning curves of operation time and complication rate, and discuss the safety and feasibility of RDP.</p><p><strong>Methods: </strong>We collected and retrospectively analyzed the single-center surgical experience of 301 patients undergoing RDP at Peking Union Medical College Hospital (PUMCH) between 2012 and 2022 and described the change in operation proficiency and occurrence of perioperative complications in this observational study. The learning curve was assessed using the cumulative sum method.</p><p><strong>Results: </strong>We observed a three-phase pattern of RDP learning with operation time, complications, and postoperative pancreatic fistula as indicators and a two-phase pattern for spleening-preserving success. The mean operation time was 3.9 hours. The incidence rate of clinically significant postoperative pancreatic fistula (CRPOPF) was 17.9% and overall Clavien-Dindo complication rate (≥3) was 16.6%. The change of postoperative complicate rate was correlated with percentage of malignant cases.</p><p><strong>Conclusion: </strong>In the last decade, an evident decrease was seen in operation time, complication rate, and an increase in the spleen-preserving rate of distal pancreatectomy. With proper training, RDP is a safe and feasible procedure.</p>","PeriodicalId":92925,"journal":{"name":"Journal of pancreatology","volume":"5 3","pages":"118-124"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2c/3f/jp9-5-118.PMC9665946.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40702410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of pancreatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1